- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01482325
SuperSTAT 2.0 Noninvasive Blood Pressure Algorithm Enhancement (SNIPE)
August 8, 2016 updated by: GE Healthcare
SNIPE:SuperSTAT 2.0 Noninvasive Blood Pressure Algorithm Enhancement
The primary objective of this study is to show that the noninvasive blood pressure software algorithm meets engineering requirements.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
31
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53210
- St. Josephs Hospital
-
Wauwatosa, Wisconsin, United States, 53226
- Wisconsin Heart Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Ability to provide written informed consent or have a legally authorized representative including a parent or guardian provide written informed consent
- Ability of a minor subject ages 7 to 18 to provide written assent
- Ability to have multiple noninvasive blood pressures taken at one sitting
- Ability to apply three lead ECG, if needed for investigation
- Ability to detect the natural presence of an irregular pulse, for irregular pulse studies
Exclusion Criteria:
- Any subject who cannot tolerate multiple blood pressure measurements
- Any subject who cannot undergo 3-lead ECG, if needed
- Any subject deemed unstable by the principal investigator
- Any subject for whom precautions are necessary because of communicable disease
- Any subject that has a known disease or condition compromises musculoskeletal integrity
- Any subject that has a known disease or condition that contraindicates use of an NIBP cuff and ECG patches on the skin.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Subjects requiring blood pressure monitoring
Any subject (neonate-adult) requiring hospital or clinic blood pressure monitoring
|
10-20 Non-Invasive Blood Pressure readings on investigational software in the DASH2500 Patient Monitor
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Data Collection for Engineering Development
Time Frame: After each iteration of software development
|
This was a data collection for engineering development to demonstrate SuperSTAT 2.0 NIBP software algorithm meets the engineering specifications. Engineers reviewed data produced by each blood pressure determination to work on new software algorithm in development. This was not conducted as program was terminated prematurely. Software iterations are not pre-defined. |
After each iteration of software development
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2011
Primary Completion (Actual)
December 1, 2013
Study Completion (Actual)
December 1, 2013
Study Registration Dates
First Submitted
November 28, 2011
First Submitted That Met QC Criteria
November 28, 2011
First Posted (Estimate)
November 30, 2011
Study Record Updates
Last Update Posted (Estimate)
September 30, 2016
Last Update Submitted That Met QC Criteria
August 8, 2016
Last Verified
August 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- 118.02-2011-GES-0002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Pressure (Low, Normal, High)
-
University of BolognaCompletedHigh-Normal Blood PressureItaly
-
China National Center for Cardiovascular DiseasesRecruitingHypertension | High-normal Blood PressureChina
-
University of Kansas Medical CenterNot yet recruitingLow Pressure Hydrocephalus
-
SE HealthCentre for Aging and Brain Health InnovationCompletedHypertension | Blood Pressure | Hypotension | High Blood Pressure | Low Blood PressureCanada
-
Maharishi International UniversityAmerican University; Abramson Family FoundationCompletedPsychological Stress | High-normal Blood PressureUnited States
-
University of VigoBayer; Hospital Clinico Universitario de SantiagoTerminatedHigh-Normal Blood Pressure | Mild Essential HypertensionSpain
-
Umeå UniversityCompletedIdiopathic Normal Pressure Hydrocephalus
-
Uppsala University HospitalUppsala University; Swedish Society for Medical ResearchRecruitingIdiopathic Normal Pressure Hydrocephalus (INPH)Sweden
-
Johns Hopkins UniversityUniversity of Utah; Integra LifeSciences CorporationCompletedIdiopathic Normal Pressure Hydrocephalus (INPH)United States, Canada, Sweden
-
Dokuz Eylul UniversityRecruitingNPH (Normal Pressure Hydrocephalus)Turkey
Clinical Trials on Blood pressure monitoring with GE Healthcare DASH2500 Patient Monitor
-
GE HealthcareTerminatedBlood PressureUnited States, India
-
William Marsh Rice UniversityCompletedPre EclampsiaUnited States
-
University of MichiganCompletedHypertensionUnited States
-
Mayo ClinicCompletedHypertension | DiabetesUnited States
-
GE HealthcareCompleted
-
Stanford UniversityLeaf Healthcare, Inc.CompletedPressure UlcerUnited States
-
GE HealthcareRecruiting
-
University Hospital, GrenobleSEFAM MEDICAL (Villiers les Nancy, France)Terminated
-
Yonsei UniversityCompletedBowel ResectionKorea, Republic of